Earnings Ahead

VRTX - Vertex Pharmaceuticals Incorporated

385.76 9.56 2.54

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

About

Profile

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharma


Headquarters

Boston, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VRTX

The biotech company stock fell 3% after issuing mixed third-quarter results. Vertex earned an adjusted $4.80 per share on revenue of $3.08 billion, versus the adjusted earnings of $4.58 per share on $3.06 billion of revenue expected from analysts polled by FactSet.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Vertex shares dip 2% as Q3 revenue, guidance falls shy of Street estimates
  • Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Biotechs rally with gene editing stocks among notable gainers
  • Vertex Pharmaceuticals Q3 2023 Earnings Preview
  • Goldman Sachs' 25 'conviction list' stocks to buy
  • Biggest stock movers today: AMD, WeWork, Paycom Software, CRISPR Therapeutics and more
  • CRISPR gains after FDA AdCom on gene editing therapy
  • CRISPR, Vertex gene editing therapy gets warm response from FDA panel
  • Gene editing stocks gain after Eli Lilly deal amid FDA AdCom
  • CRISPR on hold for trading amid key FDA meeting on gene editing drug
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • FDA reviewers recommend more studies for Vertex sickle cell therapy: report
  • Editas upgraded at Citi ahead of FDA AdCom on gene editing therapy
  • Vertex Pharmaceuticals marketing chief disposes $2M worth stock
  • Vertex Pharmaceuticals executive chairman disposes stake worth $4.85M
  • Vertex updated data on diabetes candidate VX-880 encouraging
  • Vertex appoints Atkinson EVP Chief Technical Operations Officer
  • Bluebird bio favored at Baird as sickle cell disease space gets busy
  • Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
January 26, 2022 3.37 / 3.29 2.07B / 2B Beat!
November 2, 2021 3.56 / 3.09 1.98B / 1.86B Beat!
July 29, 2021 3.11 / 2.53 1.79B / 1.72B Beat!
April 29, 2021 2.98 / 2.7 1.72B / 1.66B Beat!
February 1, 2021 2.51 / 2.57 1.63B / 1.59B Beat!
October 29, 2020 2.64 / 2.35 1.54B / 1.49B Beat!
July 30, 2020 2.61 / 2.09 1.52B / 1.39B Beat!
April 29, 2020 2.56 / 1.87 1.52B / 1.3B Beat!
January 30, 2020 1.7 / 1.21 1.26B / 1.01B Beat!
October 30, 2019 1.23 / 1.15 949.83M / 950.95M
July 31, 2019 1.26 / 1.07 941.28M / 886.16M Beat!
April 30, 2019 1.14 / 1.01 858.29M / 851.35M Beat!
February 5, 2019 1.3 / 1.06 869.44M / 820.13M Beat!
October 24, 2018 1.09 / 1.02 783.86M / 790.69M
July 25, 2018 0.94 / 0.75 751.22M / 680.64M Beat!
April 26, 2018 0.76 / 0.63 638.88M / 622.11M Beat!
January 31, 2018 0.61 / 0.53 651.6M / 595.92M Beat!
October 25, 2017 0.53 / 0.31 578.2M / 520.1M Beat!
July 26, 2017 0.39 / 0.35 1.26B / 487.5M Beat!
April 27, 2017 0.41 / 0.37 714.7M / - Beat!
Date Price Open High Low Vol Change
Dec 2 433.15 427.33
435.2
424.06
1.4M 1.77%
Dec 1 425.6 431.92
434
423.45
1.2M -1.85%
Nov 28 433.61 434.67
434.67
429.07
728K 0.33%
Nov 26 432.17 432.43
433.32
428.07
1.2M 0.55%
Nov 25 429.82 425.92
431.5
424.12
1.6M 1.37%
 
Nov 24 424 426.23
432.55
423.87
2.2M -0.65%
Nov 21 426.76 423.13
435.85
421.87
1.9M 1.05%
Nov 20 422.32 420.84
431.13
420
1.2M 0.31%
Nov 19 421.03 434.36
434.93
418.53
1.5M -3.33%
Nov 18 435.52 434
437.79
430.15
1.1M 0.35%
Nov 17 434.02 436.99
439.99
432.24
1.3M -0.72%
Nov 14 437.15 440.02
442.22
433.67
1.3M 0.61%
Nov 13 434.52 434.02
441.23
430.66
1.6M 0.08%
Nov 12 434.19 429.69
435.94
425.46
1.4M 1.16%
Nov 11 429.22 423.3
429.48
417.12
990K 1.90%
Nov 10 421.2 412.38
422.23
410.5
1.5M 2.86%
Nov 7 409.47 415.61
416.27
406.67
1.4M -1.63%
Nov 6 416.25 414.1
424.25
410.29
1.3M -0.18%
Nov 5 417 417.7
427.18
410.45
1.4M -1.11%
Nov 4 421.67 418.55
430.71
403.16
2.4M -1.02%
Nov 3 426 428.48
430.1
418.6
1.9M 0.10%
Oct 31 425.57 416.28
426.96
415.76
1.5M 1.35%
Oct 30 419.89 417.19
422.95
415
1.2M 0.64%
Oct 29 417.21 418.02
422.98
415.77
1.3M -1.23%
Oct 28 422.39 418
422.57
417.36
1.2M 0.53%
Oct 27 420.17 422
423.61
418.76
1.3M -0.29%
Oct 24 421.39 423.41
425.86
420.6
1.0M -0.29%
Oct 23 422.63 427.85
432.76
421.26
1.8M -0.89%
Oct 22 426.44 426.27
431.81
421.94
1.7M 0.04%
Oct 21 426.27 417.57
426.97
417.57
1.1M 1.71%
Oct 20 419.1 418.17
420.5
414.52
1.1M 0.55%
Oct 17 416.81 407.36
419.37
406.76
1.1M 2.01%
Oct 16 408.61 409.92
413.31
405.54
1.3M 0.17%
Oct 15 407.9 412.17
413.57
407.05
1.3M -1.05%
Oct 14 412.22 406.08
415.55
405.45
1.0M 1.19%
Oct 13 407.37 404.21
409.47
402.58
881K -0.1%
Oct 10 407.79 413.33
414.22
406.1
1.1M -1.7%
Oct 9 414.86 419.31
421.01
414.28
881K -1.49%
Oct 8 421.15 410.93
422.73
410.02
1.9M 2.65%
Oct 7 410.28 402.84
413.29
400.86
1.6M 1.83%
Oct 6 402.9 404.66
405.45
400.73
1.2M -0.1%
Oct 3 403.3 411.72
411.91
403.04
1.3M -1.36%
Oct 2 408.85 404.21
410.99
402.82
1.6M 1.15%
Oct 1 404.21 393.62
407.5
392.49
2.0M 3.21%
Sep 30 391.64 394.94
397.65
385.86
2.3M -0.93%
Sep 29 395.31 386.88
399.1
384.39
2.1M 2.48%
Sep 26 385.73 381.91
387.48
379.72
1.8M 1.01%
Sep 25 381.87 383.2
387.48
377.02
2.6M 1.39%
Sep 24 376.62 377.56
380.73
374.17
1.5M -0.82%
Sep 23 379.72 381.59
383.5
376
1.6M -0.89%
Sep 22 383.13 384.07
386.08
381.61
1.5M 0%
Sep 19 383.12 388.6
389.46
382.6
3.4M -1.03%
Sep 18 387.11 389.69
390.66
384.87
2.0M -0.01%
Sep 17 387.15 392.94
396.31
386.44
2.0M -1.08%
Sep 16 391.36 392.59
395.45
386.32
1.7M -0.47%
Sep 15 393.21 393
398.29
391.93
1.4M -0.33%
Sep 12 394.53 394.68
396.83
393.17
979K -0.71%
Sep 11 397.37 388.55
398.5
388.55
1.3M 2.27%
Sep 10 388.55 396.17
396.86
387.19
1.5M -2%
Sep 9 396.48 395.01
397.31
391.71
947K 0%